|
|||||
|
|
A long‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety,tolerability and pharmacokinetics |
|
| Authors: | Y. Guan BS F. He PhD J. Wu MD L. Zhao PhD X. Wang PhD L. Huang AS G. Zeng AS B. Ren PhD J. Chen PhD X. Liao MD Z. Ma MD X. Chen PhD G. Zhong PhD M. Huang PhD X. Zhao MS |
| Affiliation: | 1. Laboratory of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Sun Yat‐Sen University, Guangzhou, China;2. Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou, China;3. The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, China |
| Abstract: | |
| Keywords: | Jintrolong® pegylated recombinant human growth hormone (PEG‐rhGH) pharmacokinetics safety tolerability |